HPC
ALNY icon

HM Payson & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History

HM Payson & Co’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-68
Closed -$27K – 1128
2025
Q4 		$27K Buy
+68
New +$30.1K ﹤0.01% 794
2025
Q1 		– Sell
-252
Closed -$59.3K – 1040
2024
Q4 		$59.3K Buy
+252
New +$66.3K ﹤0.01% 615
2022
Q1 		– Sell
-218
Closed -$37K – 1047
2021
Q4 		$37K Buy
+218
New +$40.5K ﹤0.01% 663
2021
Q2 		– Sell
-465
Closed -$66K – 1089
2021
Q1 		$66K Buy
465
+255
+121% +$38.4K ﹤0.01% 553
2020
Q4 		$27K Sell
210
-52
-20% -$6.94K ﹤0.01% 714
2020
Q3 		$38K Buy
+262
New +$37.2K ﹤0.01% 604

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return